Literature DB >> 566561

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine.

W E Ross, D L Glaubiger, K W Kohn.   

Abstract

The effect of intercalating agents on mammalian DNA in vivo was examined by the technique of alkaline elution. Adriamycin and ellipticine were found to produce large numbers of single-strand breaks. These breaks appeared to be intimately associated with protein to the extent that enzymatic deproteinization of the DNA was necessary to reveal the breaks. The frequency of breaks and cross-links increased with concentration and time of exposure to the drugs. These data suggest that DNA single-strand scission may be a feature common to intercalators. The association with a cellular protein is previously undescribed and suggests possible mechanisms for the strand scission.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566561     DOI: 10.1016/0005-2787(78)90059-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  32 in total

1.  Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282.

Authors:  Dhriti Sooryakumar; Thomas S Dexheimer; Beverly A Teicher; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2011-06-02       Impact factor: 6.261

Review 2.  Topoisomerases, new targets in cancer chemotherapy.

Authors:  J G Zijlstra; S de Jong; E G de Vries; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription.

Authors:  William J Andrews; Tatiana Panova; Christophe Normand; Olivier Gadal; Irina G Tikhonova; Konstantin I Panov
Journal:  J Biol Chem       Date:  2013-01-04       Impact factor: 5.157

Review 4.  Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

Authors:  Atocha Romero; Trinidad Caldés; Eduardo Díaz-Rubio; Miguel Martín
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

5.  Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin.

Authors:  O Cantoni; P Sestili; F Cattabeni; C Geroni; M Grandi; F C Giuliani
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Intracellular DNA damage produced by a series of diacridines.

Authors:  I A Roos; L P Wakelin; S J Henry
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

7.  Pharmacology of mitoxantrone: mode of action and pharmacokinetics.

Authors:  D S Alberts; Y M Peng; G T Bowden; W S Dalton; C Mackel
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 8.  Topoisomerase inhibitors. A review of their therapeutic potential in cancer.

Authors:  B K Sinha
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 9.  Drugging topoisomerases: lessons and challenges.

Authors:  Yves Pommier
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

10.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.